Department of Justice
U.S. Attorney’s Office
District of Connecticut
Tuesday, Sept. 23, 2014
Follow @USAO_CT
Deirdre M. Daly, United States Attorney for the District of Connecticut, announced that WESLEY SKORSKI, 44, of Marlborough, pleaded guilty today before U.S. Magistrate Judge Donna F. Martinez in Hartford to one count of introducing a misbranded drug into interstate commerce, in violation of the Federal Food, Drug, and Cosmetic Act.
According to court documents and statements made in court, SKORSKI owns and operates AviaMed, a Wethersfield-based business licensed by the State of Connecticut to engage in the wholesale distribution of medical devices and prescription drugs under the Federal Food, Drug, and Cosmetic Act. As part of the operation of AviaMed, SKORSKI received orders for prescription drugs from physicians and other health care providers.
In 2010 and 2011, SKORSKI entered into agreements with suppliers in the United Kingdom and Canada to receive prescription drugs, including oncology and dermatology drugs, which were commercially manufactured or produced outside the U.S. for distribution in foreign markets. After receiving the drugs from the foreign suppliers, SKORSKI repackaged them and distributed them to health care providers in the U.S. outside Connecticut.
The drugs SKORSKI received from foreign suppliers failed to contain the labeling required by the Food and Drug Administration, and were not approved for sale within the U.S. As a result, the drugs were considered misbranded under the Food, Drug, and Cosmetic Act.
SKORSKI is scheduled to be sentenced on Dec. 16, 2014, at which time he faces a maximum term of imprisonment of one year and a fine of up to $1,000.
This investigation was conducted by special agents from the Food and Drug Administration, Office of Criminal Investigations. The case is being prosecuted by Assistant U.S. Attorney David J. Sheldon.
PUBLIC AFFAIRS
Source: U.S. Department of Justice, Office of the United States Attorneys
